ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ENID MILLAND M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,893Medicare Part D Prescriptions Filled, Including Refills

Rank: 486 out of 3593

$155K Total Retail Price of All Prescriptions

Rank: 2325 out of 3593

2,365 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

0% of this provider’s 2,365 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

1% of this provider’s 2,365 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,460 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$14 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

5 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 569 541 1 5
SIMVASTATIN 426 412 2 1
RANITIDINE HCL 377 363 3 27
RENAL CAPS 375 365 4 112
AZITHROMYCIN 371 342 5 34
LORATADINE 288 275 6 129
ROBAFEN-DM CLEAR 272 248 10 7 241
LISINOPRIL 233 230 8 2
TEMAZEPAM 208 198 9 56
MUPIROCIN 206 198 10 132
ALPRAZOLAM 195 190 11 37
CIPROFLOXACIN HCL 194 187 12 52
MI ACID 191 180 10 13 272
Q-TUSSIN DM 184 170 10 14 314
AMLODIPINE BESYLATE 167 158 15 3
SYNTHROID 165 160 16 51
METFORMIN HCL 164 164 17 6
FOLIC ACID 160 151 18 117
HYDROCHLOROTHIAZIDE 154 140 19 10
ATENOLOL 139 139 20 11
AMMONIUM LACTATE 124 111 21 125
TRAMADOL HCL-ACETAMINOPHEN 119 115 22 147
CLOTRIMAZOLE-BETAMETHASONE 116 109 23 94
ALENDRONATE SODIUM 115 115 24 22
FLUTICASONE PROPIONATE 115 112 24 32
PLAVIX 114 111 26 42
LOSARTAN POTASSIUM 112 106 27 14
METOPROLOL TARTRATE 111 109 28 8
PHENAZOPYRIDINE HCL 110 109 29 350
DONEPEZIL HCL 105 105 30 31
METOPROLOL SUCCINATE 92 87 31 19
GLYBURIDE 91 91 R 32 55
NEOMYCIN-POLYMYXIN-HYDROCORT 90 84 33 463
VIAGRA 89 83 34 84
FUROSEMIDE 88 88 35 9
DICLOFENAC SODIUM 82 76 36 74
ENALAPRIL MALEATE 82 82 36 38
FENOFIBRATE 81 72 38 39
IBUPROFEN 81 70 38 43
FINASTERIDE 80 80 40 79
LOPERAMIDE 79 75 41 277
LOVASTATIN 78 78 42 20
MELOXICAM 72 69 43 29
BENZONATATE 68 63 44 377
CEPHALEXIN 67 63 45 150
TAMSULOSIN HCL 64 64 46 33
PAROXETINE HCL 63 57 47 62
VOLTAREN 62 61 48 85
LEVOXYL 60 60 49 111
CITALOPRAM HBR 58 58 50 25
SERTRALINE HCL 58 58 50 28
LACTULOSE 57 57 52 126
DOXAZOSIN MESYLATE 55 55 53 63
MECLIZINE HCL 55 53 53 96
GLIPIZIDE 55 55 53 40
CARVEDILOL 55 49 53 23
PANTOPRAZOLE SODIUM 53 53 57 45
WARFARIN SODIUM 52 52 58 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.